CURE Pharmaceutical Holding Corp. (OTCQB: CURR) revenue in the third quarter increased 32.1% year-over-year and 58.9% sequentially from Q2 2022 to $1.8 million.

Q3 2022 Financial Highlights

Operational Highlights

Full story available on Benzinga.com